2Baudet E M, Puel V, Mebride J T, et al. Long - term results of value replacement with the St. Jude Medical prostesis[J ]. J Thorac Cardiovasc Surg, 1995,109: 858 - 870.?A
3Daniel J T, Rick A N, Dennis A G, et al. Modem management of prosthetic value anticoagulation[J]. Mayo Clin Proc, 1998,73: 665 - 680.?A
4Cannegieter S C, Resendaal F R, Briet B. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses[J]. Circulation, 1994,89: 634 - 641.?A
5Jaggers J J, Neal M C, Smith P K, et al. Infant cardiopulmonary bypass:A procoagulant state[J]. Ann Thorac Surg, 1999,68(2):513 -520.
6Hirsh J, Dafen J, Guyatt G. The sixth(2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis[J].Am Coll Chest Physic, 2001,119 ( 1 Suppl): 1 - 2.?A
7Weinstock D M, Chang P, Aronson D L, et al. Comparison of plasma prothrombin and factor Ⅶ and urine prothrombin FL concentrations in patients on long - term warfarin therapy and those in the initial phase[J]. Am J Hematol, 1998,57(3): 193 - 199.?A
1Emery. R W,Krogh C C,Arom K V,et al. The St. Jude Medical cardiac valve prosthesis : a 25-year experience with single valve re- placement[ J ]. Ann Thorac Surg,2005,79 ( 3 ) :776-782.
2Aksoyek A, Ulus A T,Tnton U,et al. Cardiac valve replacement with mechanical prostheses in patients aged 65 years and over[ J]. J Heart Valve Dis ,2004,13 (4) :641-650.
